Erik Swain

A once-weekly GLP-1/glucagon dual agonist reduced body weight by up to 9.8% at 76 weeks for adults with type 2 diabetes and overweight or obesity, according to findings from the SYNCHRONIZE-2 trial.

MUNICH — Community first responder activation did not improve 30-day survival in patients with out-of-hospital cardiac arrest, according to the HeartRunner trial presented at the European Society of Cardiology Congress.

PHOENIX — Tovinontrine increased plasma cyclic guanosine monophosphate levels in patients with HF with reduced or preserved ejection fraction but

In patients who underwent coronary revascularization, those with a high risk score for coronary artery disease had elevated odds of repeat revascularization or CV death compared with those with a low score, researchers reported.

BOSTON — Vascular pathology and changes in midlife play a major role in brain health later in life, suggesting that reducing cardiometabolic risk

BOSTON — Pharmaceutical treatments have led to similar weight loss to surgery and greater weight loss than was ever imaginable with lifestyle

BOSTON — Comorbidities related to cardio-kidney-metabolic syndrome have become increasingly prevalent in patients with heart failure, which has implications for prevention and treatment, according to a speaker.

BOSTON — Sleep quality affects cardiometabolic health in many ways, and it is important for healthcare professionals to routinely ask their patients about it, according to a speaker at the Cardiometabolic Health Congress.

BOSTON — Inflammation and autoimmune disease are common threads in cardiology, dermatology and rheumatology, and there is a need for collaboration across the disciplines, according to a speaker.

Key takeaways: Eating foods with well-established health recommendations is likely a better approach than adhering to a specific diet.